R42 Group logo

R42 Group

North America, California, United States, Stanford

Description

R42 Group actively invents and finances deep science ventures.

Investor Profile

R42 Group has made 25 investments, with 4 in the past 12 months and 20% as lead.

Stage Focus

  • Seed (56%)
  • Series A (16%)
  • Pre Seed (12%)
  • Series Unknown (8%)
  • Series C (4%)
  • Convertible Note (4%)

Country Focus

  • United Kingdom (64%)
  • United States (28%)
  • Switzerland (8%)

Industry Focus

  • Biotechnology
  • Health Care
  • Artificial Intelligence (Ai)
  • Life Science
  • Medical
  • Pharmaceutical
  • Software
  • Information Technology
  • Biopharma
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does R42 Group frequently co-invest with?

Emerging Longevity Ventures
North America, Florida, United States, West Palm Beach
Co-Investments: 3
Longevitytech.fund
North America, Florida, United States, Boca Raton
Co-Investments: 4
TI
Asia, Shanghai, China, Shanghai
Co-Investments: 3
Healthspan Capital
North America, California, United States, El Cerrito
Co-Investments: 3
ACF Investors
Europe, Sheffield, United Kingdom, Sheffield
Co-Investments: 3
SyndicateRoom
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 2
Cambridge Angels group
Europe, England, United Kingdom, London
Co-Investments: 5
APEX Ventures
Europe, Wien, Austria, Vienna
Co-Investments: 4
O2h Ventures
Europe, Cambridgeshire, United Kingdom, Hauxton
Co-Investments: 3
University of Cambridge Enterprise
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 4

Which angels does R42 Group often collaborate with?

JG
North America, California, United States, San Francisco
Shared Deals: 1
NR
Europe, England, United Kingdom, London
Shared Deals: 1
HG
North America, Massachusetts, United States, Boston
Shared Deals: 1
ER
North America, Massachusetts, United States, Cambridge
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 2

What are some of recent deals done by R42 Group?

Abselion

Cambridge, Cambridgeshire, United Kingdom

Abselion is the biological sensor for rapid and cost-effective detection of biological substances.

Biotechnology
Series ADec 4, 2024
Amount Raised: $8,382,496
Healx

Cambridge, Cambridgeshire, United Kingdom

Healx is a rare disease biotechnology company that uses generative AI for drug discovery.

Artificial Intelligence (AI)BiopharmaBiotechnologyHealth CareLife ScienceMedical
Series CAug 1, 2024
Amount Raised: $47,000,000
xWatts

London, England, United Kingdom

xWatts is an intelligent energy management system that helps commercial buildings reduce costs and emissions.

Energy ManagementSoftware
Pre SeedJul 18, 2024
Amount Raised: $1,800,000
Rubedo Life Sciences

Sunnyvale, California, United States

Rubedo Life Sciences focuses on developing medicines that target the specific cells responsible for aging, known as pathologic cells.

BiotechnologyHealth CareLife Science
Series AApr 22, 2024
Amount Raised: $40,000,000
Senisca

Exeter, Devon, United Kingdom

Senisca is a biotech spinout company that creates a new generation of oligonucleotide-based interventions.

BiotechnologyHealth Care
SeedMar 18, 2024
Amount Raised: $4,708,943
Reservoir Neuroscience

Emeryville, California, United States

Reservoir Neuroscience is a biopharma company that develops novel therapeutics.

BiopharmaBiotechnologyTherapeutics
Series UnknownJan 18, 2024
Amount Raised: $4,000,000
KetoSwiss

Basel, Basel-Stadt, Switzerland

KetoSwiss is a Swiss-based BioTech startup that strives to bring ketone bodies back into the modern world to combat diseases.

BiotechnologyHealth CareMedical
SeedAug 3, 2023
Amount Raised: $800,000
KetoSwiss

Basel, Basel-Stadt, Switzerland

KetoSwiss is a Swiss-based BioTech startup that strives to bring ketone bodies back into the modern world to combat diseases.

BiotechnologyHealth CareMedical
SeedOct 13, 2022
Amount Raised: $4,000,000
Silveray

Stockport, Stockport, United Kingdom

Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.

MedicalMedical Device
SeedOct 12, 2022
Amount Raised: $2,442,195
WiseWorks

London, England, United Kingdom

Meeting automation platform for corporate governance

Artificial Intelligence (AI)Communications InfrastructureNatural Language Processing
SeedJul 4, 2022
Amount Raised: $1,200,000